Compile Data Set for Download or QSAR
maximum 50k data
Found 193 with Last Name = 'nemoto' and Initial = 'n'
TargetInterleukin-17A(Homo sapiens (Human))
Saitama University

Curated by ChEMBL
LigandPNGBDBM50573258(CHEMBL4869568)
Affinity DataIC50:  70nMAssay Description:Binding affinity to biotinylated human IL-17A assessed as inhibition of IL-17A interaction with 1L-17RA by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetInterleukin-17A(Homo sapiens (Human))
Saitama University

Curated by ChEMBL
LigandPNGBDBM50573254(CHEMBL4872876)
Affinity DataKd:  110nMAssay Description:Binding affinity to human IL-17A assessed as dissociation constant in PBS-T measured after 60 mins by Biolayer interferometryMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetInterleukin-17A(Homo sapiens (Human))
Saitama University

Curated by ChEMBL
LigandPNGBDBM50573255(CHEMBL4858175)
Affinity DataKd:  12nMAssay Description:Binding affinity to human IL-17A assessed as dissociation constant in PBS-T measured after 60 mins by Biolayer interferometryMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetInterleukin-17A(Homo sapiens (Human))
Saitama University

Curated by ChEMBL
LigandPNGBDBM50573256(CHEMBL4854787)
Affinity DataKd:  89nMAssay Description:Binding affinity to human IL-17A assessed as dissociation constant in PBS-T measured after 60 mins by Biolayer interferometryMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetInterleukin-17A(Homo sapiens (Human))
Saitama University

Curated by ChEMBL
LigandPNGBDBM50573257(CHEMBL4878993)
Affinity DataKd:  13nMAssay Description:Binding affinity to human IL-17A assessed as dissociation constant in PBS-T measured after 60 mins by Biolayer interferometryMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetInterleukin-17A(Homo sapiens (Human))
Saitama University

Curated by ChEMBL
LigandPNGBDBM50573258(CHEMBL4869568)
Affinity DataKd:  6.20nMAssay Description:Binding affinity to biotinylated human IL-17A by SPR analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610865(US10626095, Example 646)
Affinity DataEC50:  620nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610866(US10626095, Example 649)
Affinity DataEC50:  2.47E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610868(US10626095, Example 657)
Affinity DataEC50:  1.16E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610869(US10626095, Example 659)
Affinity DataEC50:  810nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610870(US10626095, Example 663)
Affinity DataEC50:  1.25E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610871(US10626095, Example 718)
Affinity DataEC50:  1.51E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610872(US10626095, Example 790)
Affinity DataEC50:  980nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610873(US10626095, Example 807)
Affinity DataEC50:  1.10E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610875(US10626095, Example 931)
Affinity DataEC50:  690nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610876(US10626095, Example 934)
Affinity DataEC50:  510nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610877(US10626095, Example 944)
Affinity DataEC50:  1.01E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610878(US10626095, Example 989)
Affinity DataEC50:  800nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610879(US10626095, Example 1004)
Affinity DataEC50:  1.80E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610880(US10626095, Example 1017)
Affinity DataEC50:  1.00E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610881(US10626095, Example 1018)
Affinity DataEC50:  1.17E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610882(US10626095, Example 1248)
Affinity DataEC50:  3.05E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610883(US10626095, Example 1505)
Affinity DataEC50:  420nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610884(US10626095, Example 1573)
Affinity DataEC50:  1.03E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610885(US10626095, Example 1672)
Affinity DataEC50:  1.29E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610886(US10626095, Example 1676)
Affinity DataEC50:  2.22E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610688(US10626095, Example 1)
Affinity DataEC50:  500nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610689(US10626095, Example 2)
Affinity DataEC50:  280nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610690(US10626095, Example 3)
Affinity DataEC50:  260nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610691(US10626095, Example 4)
Affinity DataEC50:  240nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610692(US10626095, Example 5)
Affinity DataEC50:  200nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610693(US10626095, Example 6)
Affinity DataEC50:  400nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610694(US10626095, Example 7)
Affinity DataEC50:  170nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610696(US10626095, Example 8)
Affinity DataEC50:  290nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610697(US10626095, Example 9)
Affinity DataEC50:  230nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610698(US10626095, Example 10)
Affinity DataEC50:  70nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610699(US10626095, Example 11)
Affinity DataEC50:  670nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610700(US10626095, Example 12)
Affinity DataEC50:  690nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610701(US10626095, Example 13)
Affinity DataEC50:  870nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610702(US10626095, Example 14)
Affinity DataEC50:  500nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610703(US10626095, Example 15)
Affinity DataEC50:  490nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610704(US10626095, Example 16)
Affinity DataEC50:  670nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610705(US10626095, Example 17)
Affinity DataEC50:  520nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610706(US10626095, Example 18)
Affinity DataEC50:  570nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610707(US10626095, Example 19)
Affinity DataEC50:  530nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610708(US10626095, Example 20)
Affinity DataEC50:  1.62E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610709(US10626095, Example 21)
Affinity DataEC50:  770nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610710(US10626095, Example 22)
Affinity DataEC50:  650nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610711(US10626095, Example 23)
Affinity DataEC50:  450nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 13 member 5(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610712(US10626095, Example 24)
Affinity DataEC50:  0nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate™-96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 193 total ) | Next | Last >>
Jump to: